Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Doses of ALY688-SR in Generally Healthy Overweight or Obese Adults
First in human study of ALY688-SR administered as a subcutaneous injection
A Phase 1, Bioequivalence Trial Evaluating the Pharmacokinetic and Pharmacodynamic Biosimilarity of SBS6002 Versus Neulasta® Following Subcutaneous Administration to Healthy Volunteers
A Multicenter, Randomized, Double Blind, Placebo-Controlled, Phase 3 Studyto Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illnessin the Elderly
100 项与 INC Research Australia Pty Ltd 相关的临床结果
0 项与 INC Research Australia Pty Ltd 相关的专利(医药)
100 项与 INC Research Australia Pty Ltd 相关的药物交易
100 项与 INC Research Australia Pty Ltd 相关的转化医学